Skip to main content

Table 1 CD4 count at HIV care enrollment among men receiving MMT vs two comparators not receiving MMT

From: Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies

 

Number

Median age (IQR)

Median CD4 count at care enrollment (IQR), cells/mm3

p value

Males receiving MMT

28

34 (31–38)

230 (57–308)

0.541

Males whose injection drug use status was documented and not receiving MMT

237

34 (30–38)

158 (50–370)

 

Males receiving MMT

28

34 (31–38)

230 (57–308)

0.308

Males not receiving MMT

633

34(29–37)

143 (35–366)

 

Females (not self-reporting injection drug use)

306

31 (30–38)

273 (108–444)

 
  1. Females were not included in the analysis, since very few females reported injection drug use. Mann-Whitney test was used to compare the values between those receiving and not receiving MMT